Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal Miglustat in Cystic Fibrosis
NCT00945347Phase 2Completed
- Start
- Jul 2009
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cystic fibrosis (CF) comparing Miglustat with Placebo (2 arms). Primary endpoint: Change in response to Chloride-free solution and isoproterenol. Started Jul 2009; status: completed.
02
Drugs
miglustat
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT00945347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00945347.